Iterum Therapeutics plc (ITRMF)
OTCMKTS · Delayed Price · Currency is USD
0.0499
+0.0199 (66.33%)
At close: Apr 1, 2026

Iterum Therapeutics Statistics

Total Valuation

ITRMF has a market cap or net worth of 2.64 million. The enterprise value is 25.37 million.

Market Cap2.64M
Enterprise Value 25.37M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

ITRMF has 52.84 million shares outstanding. The number of shares has increased by 124.80% in one year.

Current Share Class 52.84M
Shares Outstanding 52.84M
Shares Change (YoY) +124.80%
Shares Change (QoQ) +14.69%
Owned by Insiders (%) 0.79%
Owned by Institutions (%) 5.87%
Float 52.42M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 6.76
PB Ratio -0.36
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -0.94
EV / Sales 65.05
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -1.30

Financial Position

The company has a current ratio of 2.13

Current Ratio 2.13
Quick Ratio 1.80
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF -1.73
Interest Coverage -9.53

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -53.28%
Return on Invested Capital (ROIC) -133.17%
Return on Capital Employed (ROCE) -79.16%
Weighted Average Cost of Capital (WACC) 6.35%
Revenue Per Employee 43,333
Profits Per Employee -3.00M
Employee Count9
Asset Turnover 0.02
Inventory Turnover n/a

Taxes

In the past 12 months, ITRMF has paid 276,000 in taxes.

Income Tax 276,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -95.94% in the last 52 weeks. The beta is 3.36, so ITRMF's price volatility has been higher than the market average.

Beta (5Y) 3.36
52-Week Price Change -95.94%
50-Day Moving Average 0.23
200-Day Moving Average 0.55
Relative Strength Index (RSI) 30.64
Average Volume (20 Days) 48,060,634

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.19

Income Statement

In the last 12 months, ITRMF had revenue of 390,000 and -26.96 million in losses. Loss per share was -0.74.

Revenue390,000
Gross Profit 116,000
Operating Income -20.64M
Pretax Income -26.69M
Net Income -26.96M
EBITDA -19.32M
EBIT -20.64M
Loss Per Share -0.74
Full Income Statement

Balance Sheet

The company has 11.00 million in cash and 33.74 million in debt, with a net cash position of -22.73 million or -0.43 per share.

Cash & Cash Equivalents 11.00M
Total Debt 33.74M
Net Cash -22.73M
Net Cash Per Share -0.43
Equity (Book Value) -7.38M
Book Value Per Share -0.15
Working Capital 7.30M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -19.51 million and capital expenditures -14,000, giving a free cash flow of -19.53 million.

Operating Cash Flow -19.51M
Capital Expenditures -14,000
Depreciation & Amortization 1.32M
Net Borrowing -14.75M
Free Cash Flow -19.53M
FCF Per Share -0.37
Full Cash Flow Statement

Margins

Gross Margin 29.74%
Operating Margin -5,292.31%
Pretax Margin -6,842.31%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ITRMF does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -124.80%
Shareholder Yield -124.80%
Earnings Yield -1,022.61%
FCF Yield -740.69%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on August 18, 2022. It was a reverse split with a ratio of 0.0666667.

Last Split Date Aug 18, 2022
Split Type Reverse
Split Ratio 0.0666667

Scores

ITRMF has an Altman Z-Score of -23.03 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -23.03
Piotroski F-Score 2